EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Infant Respiratory Syncytial Virus Hospitalizations Before and After Introduction of Prophylaxis Programs in Spain and the United Kingdom, June 2022–May 2025

Oliver Martyn iD, Rolf Kramer iD, Karine Mari, Scott A McDonald, Esther Dronkers iD, Rutger Schim van der Loeff, J Jasper Deuring iD, Saul N Faust iD

Open Forum Infectious Diseases · 31.10.2026 · 13 (11)

DOI: 10.1093/ofid/ofag536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.08.2026. Verfasst von Oliver Martyn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sanofi Vaccines, Lyon, France. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 2023, Europe has implemented infant respiratory syncytial virus prevention programs. Based on real-world data (2022–2025) from 5 Spanish and 19 UK hospitals, hospitalizations for respiratory syncytial virus–lower respiratory tract infection declined by 55% in Spain (77% in 0–6 months) and 18% in the United Kingdom (31% in 0–6 months), with patterns confirmed by interrupted time series analysis.

Schlagwörter

Stichwörter der Autor:innen

RSVRSVPreFhospitalizationinfantnirsevimab

Autor:innen und Institutionen

  • Sanofi Vaccines, Lyon, France.
  • P95 Clinical and Epidemiology Services, Leuven, Belgium.
  • LOGEX BV, Amsterdam, Netherlands.
  • NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, and Faculty of Medicine and Institute for Life Sciences, University of Southampton, South…

ORCID-Profile: Oliver Martyn, Rolf Kramer, Esther Dronkers, J Jasper Deuring, Saul N Faust

Förderung

  • Sanofi
  • AstraZeneca

Zitieren

APA

Martyn, O., Kramer, R., Mari, K., McDonald, S. A., Dronkers, E., Schim van der Loeff, R., Deuring, J. J., & Faust, S. N. (2026). Infant Respiratory Syncytial Virus Hospitalizations Before and After Introduction of Prophylaxis Programs in Spain and the United Kingdom, June 2022–May 2025. Open Forum Infectious Diseases, 13(11). https://doi.org/10.1093/ofid/ofag536

Vancouver

Martyn O, Kramer R, Mari K, McDonald SA, Dronkers E, Schim van der Loeff R, et al. Infant Respiratory Syncytial Virus Hospitalizations Before and After Introduction of Prophylaxis Programs in Spain and the United Kingdom, June 2022–May 2025. Open Forum Infectious Diseases. 2026;13(11). doi:10.1093/ofid/ofag536

BibTeX
@article{Martyn2026,
  author = {Martyn, Oliver and Kramer, Rolf and Mari, Karine and McDonald, Scott A and Dronkers, Esther and Schim van der Loeff, Rutger and Deuring, J Jasper and Faust, Saul N},
  title = {Infant Respiratory Syncytial Virus Hospitalizations Before and After Introduction of Prophylaxis Programs in Spain and the United Kingdom, June 2022–May 2025},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {11},
  doi = {10.1093/ofid/ofag536}
}
Kostenlos starten →